JeetoBharat
All current affairs

Advancements in Nanotechnology: Novel Nanopore Sensors for Early Neurodegenerative Disease Diagnostics

GS3

Researchers at the Rajiv Gandhi Centre for Biotechnology (RGCB) have engineered self-assembling dual-diameter nanopore sensors, marking a significant breakthrough in the early detection of Parkinson’s disease biomarkers.

The Rajiv Gandhi Centre for Biotechnology (RGCB) has achieved a notable milestone in medical diagnostics with the development of 'self-assembling dual-diameter' nanopore sensors. This innovation addresses one of the most critical challenges in neurology: the early and accurate detection of neurodegenerative conditions like Parkinson’s disease. By utilizing nanotechnology to identify specific biomarkers at an ultra-sensitive level, this technology promises to shift the paradigm from reactive treatment to proactive, early-stage intervention. Nanopore technology functions by passing molecules through a microscopic pore, where changes in electrical current reveal the identity of the molecule. The RGCB’s dual-diameter design enhances this process by providing superior resolution and sensitivity, allowing for the detection of proteins associated with Parkinson’s even at very low concentrations. This is a significant leap forward from traditional diagnostic methods, which often rely on clinical symptoms that appear only after substantial neuronal damage has already occurred.

Continue reading — free with login

JeetoBharat publishes daily UPSC current affairs mapped to the Mains syllabus. Log in to read full articles.

Log in to read full article

No credit card required. Free registered users get unlimited access.

This article was curated using AI. While we strive for accuracy, please verify critical facts from official sources.